Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.

Item
http://www.wikidata.org/entity/Q35176084
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical carePatterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cellsPIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.Endometrial cancer: Not your grandmother's cancer.Predictors for lymph nodes involvement in low risk endometrial cancer.Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancersEndometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation.The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answersMutation analysis by whole exome sequencing of endometrial hyperplasia and carcinoma in one patient: Abnormalities of polymerase epsilon and the phosphatidylinositol-3 kinase pathway.Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients.Molecular profiles of benign and (pre)malignant endometrial lesions.
P2860

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.

Item
http://www.wikidata.org/entity/Q35176084
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Molecular profiling of endomet ...... ompared to non-obese patients.
@ast
Molecular profiling of endomet ...... ompared to non-obese patients.
@en
type
label
Molecular profiling of endomet ...... ompared to non-obese patients.
@ast
Molecular profiling of endomet ...... ompared to non-obese patients.
@en
prefLabel
Molecular profiling of endomet ...... ompared to non-obese patients.
@ast
Molecular profiling of endomet ...... ompared to non-obese patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Molecular profiling of endomet ...... ompared to non-obese patients.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932